UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

A phase IIa study of tisotumab vedotin (HuMax (R)-TF-ADC) in patients with relapsed, recurrent and/or metastatic cervical cancer

Vergote, I; Dean, E; Lassen, U; de Bono, J; Drew, Y; Machiels, J-P; Nielsen, D; ... Hong, DS; + view all (2017) A phase IIa study of tisotumab vedotin (HuMax (R)-TF-ADC) in patients with relapsed, recurrent and/or metastatic cervical cancer. Presented at: 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, Spain.

Full text not available from this repository.
Type: Conference item (UNSPECIFIED)
Title: A phase IIa study of tisotumab vedotin (HuMax (R)-TF-ADC) in patients with relapsed, recurrent and/or metastatic cervical cancer
Event: 42nd European-Society-for-Medical-Oncology Congress (ESMO)
Location: Madrid, Spain
Dates: 08 - 12 September 2017
Language: English
Keywords: Science & technology, life sciences & biomedicine, oncology.
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology
URI: http://discovery.ucl.ac.uk/id/eprint/10040086
Downloads since deposit
1Download
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item